Purchases and Sales Made in Q2 2023 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q2 2023. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
3.94KNew |
$19.4K - $26.6K
|
3.94K
$7.88K
|
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
3.93K+ 62.68% |
$19.4K - $26.5K
|
10.2K
$20.4K
|
|
|
Jul 26, 2023
Q2 2023
|
Dorsey Wright & Associates
|
BUY
|
- |
3.45KNew |
$17K - $23.2K
|
3.45K
$6.89K
|
|
|
Aug 11, 2023
Q2 2023
|
Amalgamated Bank
New York, NY |
BUY
|
- |
3.29KNew |
$16.2K - $22.2K
|
3.29K
$6.58K
|
|
|
Aug 14, 2023
Q2 2023
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
3.26KNew |
$16K - $21.9K
|
3.26K
$6.51K
|
|
|
Aug 11, 2023
Q2 2023
|
Ameritas Investment Partners, Inc.
Lincoln, NE |
BUY
|
- |
2.8KNew |
$13.8K - $18.8K
|
2.8K
$5.59K
|
|
|
Aug 10, 2023
Q2 2023
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
1.87KNew |
$9.21K - $12.6K
|
1.87K
$3.74K
|
|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
1.48K+ 236.9% |
$7.31K - $10K
|
2.11K
$4.22K
|
|
|
Aug 14, 2023
Q2 2023
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
381New |
$1.88K - $2.57K
|
381
$762
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-800- 0.68% |
$3.94K - $5.39K
|
117K
$233K
|
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-4.11K- 98.28% |
$20.3K - $27.7K
|
72
$144
|
|
|
Aug 04, 2023
Q2 2023
|
Parallel Advisors, LLC
|
SELL
|
- |
-4.44K- 22.35% |
$21.9K - $29.9K
|
15.4K
$30.9K
|
|
|
May 20, 2024
Q2 2023
|
Parallel Advisors, LLC
|
SELL
|
- |
-4.44K- 22.35% |
$21.9K - $29.9K
|
15.4K
$30.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-10.5K- 74.77% |
$52K - $71K
|
3.56K
$7.11K
|
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-15.1K- 0.35% |
$74.6K - $102K
|
4.25M
$8.5M
|
|
|
Aug 14, 2023
Q2 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-21.4K- 7.89% |
$106K - $144K
|
250K
$501K
|
|
|
Aug 14, 2023
Q2 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-67.2K- 34.44% |
$331K - $453K
|
128K
$256K
|
|
|
Aug 11, 2023
Q2 2023
|
Chi Advisors LLC
New York, NY |
SELL
|
- |
-147K- 10.96% |
$726K - $992K
|
1.2M
$2.39M
|
|
|
Aug 14, 2023
Q2 2023
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-504KClosed |
$2.49M - $3.4M
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-648K- 81.66% |
$3.2M - $4.37M
|
146K
$291K
|
|
|
Aug 14, 2023
Q2 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-650K- 36.47% |
$3.2M - $4.38M
|
1.13M
$2.26M
|
|
|
Aug 14, 2023
Q2 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-1.61M- 49.41% |
$7.92M - $10.8M
|
1.64M
$3.29M
|